<DOC>
	<DOCNO>NCT01493180</DOCNO>
	<brief_summary>The purpose study evaluate efficacy OPC-12759 ophthalmic suspension patient keratoconjunctival epithelial disorder compare sodium hyaluronate . Also , safety OPC-12759 assess .</brief_summary>
	<brief_title>Exploratory Study OPC-12759 Ophthalmic Suspension</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Diagnosis superficial punctate keratopathy , corneal erosion persistent epithelial defect 2 . Fluorescein corneal stain score 3 high 1 . Active ocular infection 2 . Vernal keratoconjunctivitis 3 . Recurrent corneal erosion 4 . Physical irritation eyelash relax bulbar conjunctiva cornea conjunctiva 5 . Subjects discontinue anticipate use eye drop except limited concomitant one study . Softsantear allow screening period . 6 . Anticipated use contact lens study . 7 . Insertion punctal plug fall punctal plug within 3 month 8 . Subjects judge investigator ineligible study past concurrent systemic disease . 9 . Receipt investigational product within 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>